Augmedix/AUGX

$4.57

3.86%
-
1D1W1MYTD1YMAX

About Augmedix

Augmedix, Inc. helps clinicians and patients form a human connection at the point of care. The Company uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. It also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patient’s health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.

Ticker

AUGX

Sector

Industrials

Trading on

NASDAQ

Industry

Computer Services

CEO

Emmanuel Krakaris

Employees

1,040

Headquarters

San francisco, United States

Augmedix Metrics

BasicAdvanced
$217.61M
Market cap
-
P/E ratio
-$0.50
EPS
-
Beta
-
Dividend rate

What the Analysts think about Augmedix

Analyst Ratings

Majority rating from 5 analysts.
Buy

Price Targets

Average projection from 5 analysts.
48.36% upside
High $8.00
Low $5.90
$4.57
Current price
$6.78
Average price target

Augmedix Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-37.6% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$11.7M
9.35%
Net income
$-4.4M
-12%
Profit margin
-37.6%
-19.52%

Augmedix Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 14.89%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
-$0.15
-$0.14
-$0.12
-$0.10
-
Expected
-$0.15
-$0.15
-$0.13
-$0.12
-$0.10
Surprise
-2.17%
-8.2%
-7.69%
-14.89%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Augmedix stock

Buy or sell Augmedix stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing